To empower Canadians to take control of their

health by accelerating access to innovative therapies and technologies, and bridging healthcare gaps through dynamic collaborations.


With rapid advances in healthcare innovation globally, Canadians often face challenges or delays in accessing the latest therapies and technologies.


At Enoumena Therapeutics, we are a dedicated team committed to bridging this gap by proactively seeking and delivering thoughtful solutions that improve the lives of Canadian patients and enhance the healthcare ecosystem.

 

Peter Melnyk, PhD - Founder & CEO

Peter Melnyk is a leader in the life sciences and pharmaceutical industry with over 30 years of experience. With a PhD in Pathology from McGill University, his career began with a focus on cardiac arrhythmias at the Montreal Heart Institute. This early work fueled his passion for healthcare innovation, leading to a career dedicated to improving access to new therapies. He held leadership roles at Novartis and Otsuka before founding Enoumena Therapeutics. His company is focused on bringing impactful solutions to Canadian patients and healthcare providers through strategic partnerships and collaborations. Peter also serves on the Board of Directors for the Canadian Association for Healthcare Reimbursement.

Team

Enoumena Therapeutics is driven by a committed team of highly experienced professionals, united by a singular focus on advancing patient health through rigorous science and ethical practice.

A Foundation of Deep Canadian Experience

Our current structure ensures that all critical functions are managed by experts with significant, established track records. Every member of our team is a Canadian professional, providing an inherent understanding of the Canadian regulatory, healthcare, and business landscape.

Specialized Functional Expertise

Our team is composed of dedicated specialists covering the essential pillars of a successful biopharmaceutical enterprise:


  • Medical Affairs and Medical Information: Driving scientific communications and ensuring accurate, balanced data dissemination.

  • Drug Safety and Pharmacovigilance: Maintaining the highest standards for patient safety and continuous monitoring of our therapeutic programs.

  • Legal Affairs: Providing expert counsel to navigate the complexities of pharmaceutical law, regulatory compliance, and corporate governance.

Depth of Experience

The collective experience of our core team is a cornerstone of our operational strength. Each team member brings 25 or more years of industry-specific experience, ensuring knowledgeable leadership and strategic excellence.